INC Research acquires Middle Eastern CRO MEK Consulting
US-based clinical research organization (CRO) INC Research has extended its global footprint into the Middle East and North Africa (MENA) with the acquisition of MEK Consulting.
Read MoreAuthor: Peter Mansell
MAHSC, Roche partner for research, access to innovation
Roche has chosen Manchester for its first partnership with an Academic Health Science Centre (AHSC), the new format that brings together top universities and NHS organisations in the UK with the common goal of facilitating patient access to breakthroughs in clinical research.
Read MoreHarlan CRS, Bertin Pharma team for early development
US-based toxicology specialist Harlan Contract Research Services (CRS) has formed a strategic partnership for early drug-development services with Bertin Pharma, a French provider of global R&D-outsourcing services and bioreagent tools.
Read MoreJAMA study finds 5-16% gap in federal CT oversight
Between 5% and 16% of clinical trials conducted in the US fall into a regulatory gap between existing provisions for drugs and medical devices, a new study indicates.
Read MoreNew office, partnership for Celerion in South Korea
Celerion has become the latest clinical-research organisation (CRO) to put down roots in South Korea, which is attracting growing interest as a preferred location for drug development.
Read More- RougeTx launches with $58 million series A financing for HHT therapy
- Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
- Bespak and SNBL agree global access deal for FDA‑approved nasal device
- NEMLUVIO data show sustained three‑year responses in atopic dermatitis
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
